SCHOTT Pharma introduces blister-free syringe concept

Published: 2-Oct-2024

As part of the Alliance to Zero goal to facilitate the pharmaceutical industry's transition to net-zero emissions, SCHOTT Pharma has teamed up with Schreiner MediPharm and Körber Pharma to develop a groundbreaking blister-free syringe concept

Traditionally, blister packs are used to ensure the integrity and protection of prefilled syringes en route to the patient, as well as to provide a first-opening indicator.

This new system combines a syringe, cap, functional label and a carton to cover the blister functionality.

In addition to replacing single-use polymer packaging, it simplifies the entire value chain, including significant benefits for transportation efficiency and environmental impact.

"Innovation and sustainability are at the core of SCHOTT Pharma's mission. This innovative blister-free syringe concept is proof of how we integrate sustainable practices into our products and solutions for our customers," said Andreas Reisse, CEO of SCHOTT Pharma.

The newly developed secondary packaging concept for prefilled syringes represents a significant step forward in sustainable secondary packaging.

The folded carton, which is made entirely of 100% cardboard mono material, ensures that the prefilled syringes are protected against mechanical impacts and dust just as reliably as its polymer predecessor.

It also maintains the visibility of labels and expiration dates, ensuring that the syringes are easily accessible and identifiable.

At the same time, the combination of syringe, cap and label provides tamper evidence. This feature eliminates unnecessary syringe waste as the tamper evidence accounts for each individual syringe, not for the entire blister pack.

Positive results from first case study

A case study conducted by the three companies focused on blister-free prefillable polymer syringes for hospital use found major advances for healthcare workers and the whole supply chain.

The new system simplifies the usage for nurses and doctors as it is much easier to open than traditional blister packaging.

In addition, it is easier to dispose of. Using only cardboard material means fewer waste streams and a simpler recycling process. It also takes up less space in the bin as it is not as rigid and bulky as blister – a big bonus as space is an important factor in the hospital ward.

For the supply chain, one of the outstanding features of this new packaging concept is its optimisation for packaging density.

Like this story? Subscribe to Manufacturing Chemist magazine for the latest news, updates and expert-written articles from the global pharmaceutical and biopharma sectors. For more information click here.

The new packaging concept supports a 25% increase in packaging density.

Hence, it reduces the number of trucks needed for transportation and the storage space required along the supply chain. In addition to reducing the carbon footprint of the entire supply chain by up to 58%, the optimisation leads to a reduction in logistics costs.

You may also like